Britain’s Izana Bioscience Tests Rheumatoid Arthritis Drug On COVID-19 Sufferes Britain’s Izana Bioscience Tests Rheumatoid Arthritis Drug On COVID-19 Sufferes By Leslie Allen on April 6, 2020 UK-based biopharma firm Izana Bioscience said it was testing its antibody therapy namilumab for the therapy of patients with quickly worsening COVID-19 at the Humanitas…